With recent innovation and policy movement related to the pharmaceutical supply chain, are we on the verge of demonstrable change that will promote greater transparency and affordability for prescription drugs? On this episode of the Business Group on Health podcast, we speak with Dr. Karen Van Nuys, Executive Director of the Value of Life Sciences Innovation program at the USC Schaeffer Center, about this very question. In our conversation, Dr. Van Nuys highlights her research on pharmaceutical distribution, learnings from the insulin market and how employers can prepare to respond to the potential policy changes ahead. We also address emerging innovation and disruptions taking place in the pharmaceutical industry and how they will shape drug pricing and affordability.

Guest: Karen Van Nuys, PhD, Executive Director, Value of Life Sciences Innovation Project, Leonard D. Schaeffer Center for Health Policy and Economics

Thank you to today’s episode sponsor Color

Tags: Business Group on Health, drug affordability, drug pricing, insulin, pharmaceuticals, pharmacy, pharmacy benefit manager, pharmacy supply chain
 
Posted in: Audio Podcast, Business Group on Health, Healthcare